On April 6, 2021 Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary RADR artificial intelligence ("A.I.") platform to transform oncology drug discovery and development reported that Panna Sharma, President and CEO of Lantern Pharma, will participate in the 20th Annual Needham Healthcare Conference, to be held virtually on April 12-15, 2021 (Press release, Lantern Pharma, APR 6, 2021, View Source/news/press-releases/detail/46/lantern-pharma-to-participate-in-the-virtual-20th-annual" target="_blank" title="View Source/news/press-releases/detail/46/lantern-pharma-to-participate-in-the-virtual-20th-annual" rel="nofollow">View Source [SID1234577629]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Mr. Sharma will participate in a fireside chat moderated by Needham & Company’s Alexander Salisbury on Thursday, April 15, at 12:45 pm ET and hold one-on-one meetings with investors throughout the four-day event.

The live event will be accessible on View Source and will be archived for 90 days. Investors interested in scheduling a meeting with Mr. Sharma should contact their Needham & Company representative or Lantern Pharma investor relations.